(Q51745561)

English

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh.

scientific article published on 30 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

Shigella flexneri

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Robert E. Black

15

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Muntasirur Rahman

object named as

Muntasirur Rahman

10

0 references

author name string

Kazi Mizanur Rahman

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Shams El Arifeen

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

K Zaman

3

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Mahbubur Rahman

4

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Mohammad Yunus

6

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Nazma Begum

7

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Md Shaheenul Islam

8

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Badrul Munir Sohel

9

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Malabi Venkatesan

11

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Thomas L Hale

12

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Daniel W Isenbarger

13

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Philippe J Sansonetti

14

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Abdullah H Baqui

16

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

language of work or name

0 references

publication date

30 October 2010

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

29

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

6

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

1347-1354

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Death in shigellosis: incidence and risk factors in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Efficacy of oral poliovirus vaccine in rural communities of North Arcot District, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.035

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.10.035

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/21040694

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51745561&oldid=1368990278"